Vaccines for hantaviruses: progress and issues

@article{Schmaljohn2012VaccinesFH,
  title={Vaccines for hantaviruses: progress and issues},
  author={Connie S. Schmaljohn},
  journal={Expert Review of Vaccines},
  year={2012},
  volume={11},
  pages={511 - 513}
}
  • C. Schmaljohn
  • Published 1 May 2012
  • Biology, Medicine
  • Expert Review of Vaccines
Abstract : The Hantavirus genus of the family Bunyaviridae comprises more than 20 viruses, including several human pathogens. Hantaviruses are maintained in rodent reservoirs and are usually transmitted to humans in aerosols of rodent excreta. Oldworld rodents carry viruses that cause hemorrhagic fever with renal syndrome (HFRS) and new-world rodents carry viruses that cause hantavirus pulmonary syndrome (HPS). Four hantaviruses cause most cases of HFRS in Asia and Europe: Hantaan (HTNV), Seoul… Expand
Current Status of Hantavirus Vaccines Development
TLDR
The current and novel hantavirus vaccines are discussed in terms of the demand, population at risk, and the potential market size for specific endemic areas. Expand
Vaccines and Therapeutics Against Hantaviruses
TLDR
The epidemiology, virology, and pathogenesis of four HFRS-causing viruses, HTNV, SEOV, PUUV, and DOBV, and two HCPS-ca causing viruses, ANDV and SNV are summarized and it is thought that this information will shed light on the rational development of new vaccines and treatments. Expand
Progress on the Prevention and Treatment of Hantavirus Disease
TLDR
This review provides a summary of the status of vaccine and antiviral treatment efforts including those tested in animal models or human clinical trials. Expand
Of voles and men: novel Hantavirus in vitro models
TLDR
Establishment of novel in vitro models, studies of different aspects of hantavirus-infection were performed, and a 3-dimensional organotypic model of human lung tissue was used to study early and long term infections of the highly pathogenic Andes virus (ANDV). Expand
Hantavirus Infections—Treatment and Prevention
TLDR
This review summarizes all the efforts undertaken to develop medical countermeasures in vitro, in vivo, and human clinical trials against Hantavirus infections. Expand
Chapter 3 – Hantavirus Infections
TLDR
The clinical presentation of hantavirus infections varies from subclinical, mild/moderate, and severe to fatal, depending on the causative agent and patient-specific determinants. Expand
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
ABSTRACT Hantavirus pulmonary syndrome (HPS) is caused by infection with several Sigmodontinae- and Neotominae-borne hantaviruses and has a case fatality rate of 30 to 50%. Humans often becomeExpand
Hantavirus infection in North America: a clinical review.
TLDR
The epidemiology, presentation, workup, and treatment for hantavirus cardiopulmonary syndrome is reviewed, with patients with severe respiratory symptoms with rodent exposure or rural/wilderness travel facing a rapidly worsening respiratory phase requiring rapid intensive care unit admission. Expand
HFRS and hantaviruses in the Balkans/South-East Europe.
TLDR
Balkans represent an area with a potential need for hantavirus vaccines, but due to co-existence of DOBV and PUUV causing HFRS in the same region, a universal vaccine is required. Expand
Therapeutic Approaches for New World Hantaviruses
TLDR
Clinical acumen is best accomplished by a combination of clinical acumen for the recognition of the chief risk factor, namely exposure to rodent excreta, combined with early referral and transfer to a clinical centre capable of providing advanced cardiopulmonary support. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Vaccines for hantaviruses.
TLDR
This review addresses the significance of hantaviruses as they relate to biodefense and provides information about conventional and molecular vaccines for HFRS that have advanced to clinical studies. Expand
A lethal disease model for hantavirus pulmonary syndrome.
TLDR
The characteristics of the disease in hamsters, including the incubation period, symptoms of rapidly progressing respiratory distress, and pathologic findings of pulmonary edema and pleural effusion, closely resemble HPS in humans. Expand
A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease
TLDR
Current concepts regarding the ecology of and disease associated with these serious human pathogens are presented and an integration of the ecology and evolution of these and other host-virus ecosystems through modeling and hypothesis-driven research with the risk of emergence, host switching/spillover, and disease transmission to humans. Expand
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness.
TLDR
A mysterious respiratory illness with high mortality was recently reported in the southwestern United States and nucleotide sequence analysis revealed the associated virus to be a new hantavirus and provided a direct genetic link between infection in patients and rodents. Expand
Review of an Inactivated Vaccine against Hantaviruses
TLDR
The inactivated hantavirus vaccine was well tolerated and there were no apparent differences in the responses in human subjects, however, further improvement of this vaccine is necessary in order to induce a longer-lasting humoral immune response. Expand
DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters against Three of Four HFRS Hantaviruses and Elicits a High-Titer Neutralizing Antibody Response in Rhesus Monkeys
TLDR
Protection data in hamsters combined with the immunogenicity data in monkeys suggest that hantavirus M gene-based DNA vaccines could protect humans against the most severe forms of HFRS. Expand
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
TLDR
The results demonstrate that the HTNV and PUUV DNA vaccines are safe and can be immunogenic in humans when delivered by PMED. Expand
Hantavirus Pulmonary Syndrome, United States, 1993–2009
TLDR
Increased hematocrits, leukocyte counts, and creatinine levels were more common in HPS case-patients who died, and cases continue to occur. Expand
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010.
  • P. Heyman, C. Ceianu, +25 authors A. Vaheri
  • Medicine, Biology
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2011
TLDR
An overview of the progression of human cases in the period from 2005 to 2010 is presented and an update on the available diagnostic methods and endemic regions in their countries is provided, with an emphasis on occurring virus types and reservoirs. Expand
Puumala virus infections in Finland: increased occupational risk for farmers.
TLDR
Cases among farmers and the population living in similar conditions were compared, and cases among farmers contracted the disease earlier and more often than did the comparison group. Expand
...
1
2
3
...